Effectiveness of antenatal steroids in obstetric subgroups

Area of Science:

• Neonatal Medicine
• Obstetrics
• Perinatology

Background:

• Antenatal steroid administration is a cornerstone of preterm birth management.
• Understanding its efficacy across diverse obstetric scenarios is crucial for optimizing neonatal outcomes.

Purpose of the Study:

• To evaluate the effectiveness of antenatal steroids in reducing neonatal morbidity and mortality.
• To analyze outcomes in specific obstetric subgroups: preterm labor with intact membranes, preterm premature rupture of membranes (PROM), and pregnancy-associated hypertension.
• To assess the impact on appropriate for gestational age (AGA) and growth-restricted neonates.

Main Methods:

• Retrospective analysis of 1148 neonates weighing ≤1750g, delivered between 1990-1997.
• Neonates categorized into preterm labor (intact membranes), PROM, and pregnancy-associated hypertension groups.
• Further stratification into AGA and growth-restricted neonates.
• Comparison of outcomes (RDS, IVH/PVL, NEC, sepsis, death) between steroid-exposed and unexposed neonates within subgroups.

Main Results:

• Antenatal steroids significantly reduced Respiratory Distress Syndrome (RDS), intraventricular hemorrhage/periventricular leukomalacia (IVH/PVL), necrotizing enterocolitis, and mortality in preterm labor with intact membranes.
• In PROM, steroids decreased IVH/PVL incidence and severity, and neonatal mortality, but not RDS.
• No benefit observed in pregnancy-associated hypertension or fetal growth restriction (FGR); increased sepsis noted with steroids in hypertensive pregnancies.

Conclusions:

• The effectiveness of antenatal steroids is population-dependent.
• Significant benefits in reducing neonatal morbidity and mortality observed in AGA preterm neonates from preterm labor with intact membranes.
• No demonstrated benefit for hypertensive pregnancies or FGR; limited benefits in PROM.